Skip to main content

Table 1 Transplant donor and recipient characteristics, including genetic HLA types

From: Case report: de novo ANCA-associated vasculitis after kidney transplantation treated with rituximab and plasma exchange

 

Donor

Recipient

Age (years)

73

65

Gender

male

female

CMV serostatus

positive

positive

MHC class I

A*02, 68

A*01, 32

B*51,53

B*35, −

C*04,14

C*04, −

MHC class IIa

DRB1*13, 08

DRB1*11, 14

DQB1*06, 04

DQB1*03, 05

Panel reactive antibody

 

0%

Cold ischaemia time (hours)

10,5

  1. aHLA-DP was not tested as part of the transplant matching process
Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us